BAX vs. IBB
BAX (Baxter International Inc.) is a stock, while IBB (iShares Nasdaq Biotechnology ETF) is Health & Biotech Equities fund tracking the NASDAQ Biotechnology Index. Over the past 10 years, BAX returned -6.26%/yr vs 8.14%/yr for IBB. At a 0.42 correlation, their price movements are largely independent.
Performance
BAX vs. IBB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BAX achieves a 2.98% return, which is significantly lower than IBB's 4.97% return. Over the past 10 years, BAX has underperformed IBB with an annualized return of -6.26%, while IBB has yielded a comparatively higher 8.14% annualized return.
BAX
- 1D
- -1.16%
- 1M
- 2.56%
- YTD
- 2.98%
- 6M
- 3.69%
- 1Y
- -33.88%
- 3Y*
- -22.55%
- 5Y*
- -23.11%
- 10Y*
- -6.26%
IBB
- 1D
- 1.94%
- 1M
- 4.88%
- YTD
- 4.97%
- 6M
- 2.54%
- 1Y
- 41.38%
- 3Y*
- 11.58%
- 5Y*
- 2.25%
- 10Y*
- 8.14%
BAX vs. IBB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BAX Baxter International Inc. | 2.98% | -33.28% | -22.40% | -21.91% | -39.58% | 8.48% | -2.95% | 28.40% | 2.89% | 47.30% |
IBB iShares Nasdaq Biotechnology ETF | 4.97% | 27.98% | -2.41% | 3.76% | -13.69% | 0.95% | 26.01% | 25.42% | -9.53% | 21.08% |
Correlation
The correlation between BAX and IBB is 0.32, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.32 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.38 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.38 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.40 |
Correlation (All Time) Calculated using the full available price history since Feb 12, 2001 | 0.42 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BAX vs. IBB — Risk / Return Rank
BAX
IBB
BAX vs. IBB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Baxter International Inc. (BAX) and iShares Nasdaq Biotechnology ETF (IBB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BAX | IBB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.77 | ||
| Sortino ratioReturn per unit of downside risk | -3.65 | ||
| Omega ratioGain probability vs. loss probability | 0.88 | 1.34 | -0.46 |
| Calmar ratioReturn relative to maximum drawdown | -0.69 | 4.32 | -5.01 |
| Martin ratioReturn relative to average drawdown | -1.00 | 13.28 | -14.28 |
Loading charts...
Drawdowns
BAX vs. IBB - Drawdown Comparison
The maximum BAX drawdown since its inception was -81.15%, which is greater than IBB's maximum drawdown of -62.85%. Use the drawdown chart below to compare losses from any high point for BAX and IBB.
Loading charts...
Drawdown Indicators
| BAX | IBB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -81.15% | -62.85% | -18.30% |
Max Drawdown (1Y)Largest decline over 1 year | -49.00% | -9.63% | -39.37% |
Max Drawdown (3Y)Largest decline over 3 years | -65.90% | -24.85% | -41.05% |
Max Drawdown (5Y)Largest decline over 5 years | -80.61% | -39.82% | -40.79% |
Max Drawdown (10Y)Largest decline over 10 years | -81.15% | -39.82% | -41.33% |
Current DrawdownCurrent decline from peak | -76.53% | -0.27% | -76.26% |
Average DrawdownAverage peak-to-trough decline | -21.68% | -21.15% | -0.53% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 34.04% | 3.12% | +30.92% |
Volatility
BAX vs. IBB - Volatility Comparison
Baxter International Inc. (BAX) has a higher volatility of 10.05% compared to iShares Nasdaq Biotechnology ETF (IBB) at 6.96%. This indicates that BAX's price experiences larger fluctuations and is considered to be riskier than IBB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BAX | IBB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.05% | 6.96% | +3.09% |
Volatility (6M)Calculated over the trailing 6-month period | 32.53% | 15.99% | +16.54% |
Volatility (1Y)Calculated over the trailing 1-year period | 46.76% | 20.37% | +26.39% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.89% | 22.03% | +11.86% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 29.36% | 23.22% | +6.14% |
Dividends
BAX vs. IBB - Dividend Comparison
BAX's dividend yield for the trailing twelve months is around 1.02%, more than IBB's 0.23% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BAX Baxter International Inc. | 1.02% | 2.72% | 3.57% | 3.00% | 2.26% | 1.26% | 1.19% | 1.02% | 1.11% | 0.94% | 1.14% | 87.05% |
IBB iShares Nasdaq Biotechnology ETF | 0.23% | 0.23% | 0.29% | 0.26% | 0.31% | 0.21% | 0.21% | 0.33% | 0.20% | 0.30% | 0.19% | 0.03% |
Frequently Asked Questions
BAX and IBB have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BAX has higher volatility (10.05%) compared to IBB (6.96%). In terms of maximum drawdown, BAX dropped -81.15% vs IBB's -62.85%.
IBB currently has the higher Sharpe Ratio (2.05 vs -0.73), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BAX and IBB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer